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Tyrosinase is the principal enzyme in the biosynthesis of 
melanin. The expression of tyrosinase is tissue-specific and 
appears to be regulated by various hormonal and environ-
mental factors. Elucidation of the genomic structure and mo-
lecular basis of control of tyrosinase gene expression will 
greatly enhance our understanding of the regulation of 
human pigmentation. To this end, we have isolated and per-
formed restriction mapping of recombinant cosmid and 
lambda phage clones containing the human tyrosinase gene, 
sequenced a 2.2-kilobase (kb) region of its promoter, and 
determined the potential regions regulating the tyrosinase 
gene expression in transient-expression system. The human 
tyrosinase gene is comprised of five exons and four introns. 
Based on our restriction mapping studies, the gene spans a 
distance of over 65-kb on chromosome 11 (q14 - q21). We 
constructed a series of plasmids (pHTY -CAT) that contain 5' 
sequential deletions of the human tyrosinase 5' flanking se-
quence fused to the reporter gene, chloramphenicol acetyl-
T yrosinase (monophenol monooxygenase; mono-phenol, L-dopa: oxygen oxidoreductase, E.C. 1.14.18.1) is the core enzyme in melanogenesis, and is expressed in a tissue-specific manner among pigment cells [1,2] . Previously, we isolated and characterized a 
human tyrosinase cDNA [3], and mapped its chromosomal location 
to the q arm of chromosome 11 [4]. Subsequently, we and several 
other laboratories reported the human and mouse tyrosinase cDNA 
sequences [5 - 8]. The gene encoding tyrosinase in humans com-
prises five exons, and a partial characterization of this gene has also 
been reported [9]. 
Our earlier observations in the mouse indicated that the gene for 
tyrosinase is encoded by the genetically well-characterized c locus 
[3,10]. This encoding has been demonstrated by the rescue of a c 
locus mutant-albino through the introduction of functional tyro-
sinase minigene constructs into mice [11,12]. We showed that 2.1 
kb of the 5' flanking sequence was sufficient to provide appropriate 
developmental regulation of tyrosinase gene expression, including 
induction of pigmentation in the retinal pigment epithelial cells 
[13]. Kluppel et af [14] have also indicated that melanocyte-specific 
expression of the tyrosinase gene in mice could be obtained with as 
little as 270 base pairs (bp) of 5' fiallking sequence, thereby suggest-
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transferase (CAT). The plasmids were used to locate pro-
moter regions that are potential regulators of tyrosinase gene 
expression in a transient expression system using melanoma 
cell lines. In human melanoma cells, the plasmid construct 
with a -2020 base pair (bp) promoter yielded the highest 
CAT activity. When the deletions reached -1739 bp, the 
CAT activity was dramatically reduced, indicating that im-
portant enhancer elements for transcription control are 
present between -1739 and -2020 bp. Further deletions up to 
-550 bp also resulted in dramatic decreases of CAT activity. 
However, when the deletion included -550 bp of the 5' 
flanking sequence, there was 26 percent of the CAT activity 
compared to that of the -2020 bp promoter. Deletions 
beyond -550 bp also showed markedly decreased CAT activ-
ity. Based on our data, we suggest that human tyrosinase gene 
expression is governed by both tissue-specific and multiple 
regulatory elements. ] Invest Dermato11 02:744- 748, 1994 
ing that cis-acting elements determining the expression of the 
mouse tyrosinase gene should lie within the small promoter region. 
On the contrary, in humans, this important information 011 the 
transcriptional control region is yet to be established. We and others 
have earlier reported the molecular basis of tyrosinase-negative ocu-
locutaneous albinism in humans that causes a defect in melanin 
biosynthesis [15 -18]. The mutations observed so far were found to 
be associated only with the coding region of the tyrosinase gene. 
Elucidation of the detailed organization of the promoter region 
could also help to identify any molecular defects that affect tran-
scriptional control of the tyrosinase gene. Analysis of promoter 
function becomes essential to identify cis-acting elements and trallS-
acting factors that direct tissue-specific and developmentally con-
trolled expression of the human tyrosinase gene. These analyses are 
key to the understanding of the regulation of human pigmentation 
and certain forms of pigmentation disorders such as human hypo-
pigmentation and albinism. 
In this context, we have constructed a partial restriction map of 
the entire human tyrosinase gene including the promoter region, 
determined the sequence of the 2.2-kb promoter region, identified 
the transcription start sites, and characterized promoter functions in 
a transient expression system. 
MATERIALS AND METHODS 
Cell Culture The human melanoma cell lines Stilling (YUSIT 1) and 
Genovese were obtained from Dr. Ruth Halaban of Yale University School 
of Medicine and cultured in FlO medium (Gibco Laboratories, Grand Island, 
NY) supplemented with 10% feta l bovine serum and 50 U /ml of penicillin 
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Figure 1. Structural organization of the human tyrosinase gene ~n chromosome 11 q 14-q21. The restriction sites and intron~exon locations indicat:d were 
determined by the restnctlon mapp1l1g strategy outl1l1ed 111 Materoais al/d Methods. The scale denotes the length of the gene 111 blobase pairs. AbbreViations for 
the restriction enzyme sites are II, Bgl II; V, EcoR V; B, BamH I; E, EcoR I; H, Hind III; P, Pst I; S, Sal I; and X, Xba I. 
and streptomycin, and RPMI medium (Gibco) with 10% fetal bovine serum 
and antibiotics, respectively. HeLa cells were obtained from the Amencan 
Type Culture Collection and ~rown in Dulbecco:S modified Eagle's me-
dium with 10% new-born bov1l1e serum and antibIOtiCS as above. 
Restriction Mapping Five overlapping recombinant cosmid and lambda 
phage clones containing regions of the.human tyrosinase gene were isolated 
by screening human genomIC library (lll pJBB cosrrud and EMBL3 ve~tors) 
with the human tyrosinase cDNA probe, Pme! 34 (3). The recombmant 
clones isolated were named pCos2BA, p}.TY3, p}.TYIII, p}.TYIV, and 
pCosTYV. DNA of the clone pCos2BA was digested with restriction en-
zymes BamH I, Bgl II, EcoR I, EcoR V, Hind III, Pst I, Sal I, and Xba I in 
both single and double d,gestlons, and that of the clones p}.TY3, p}.TYIII, 
pA-TYIV, and pCosTYV were digested with Pst I and SaIl. The digested 
products were separated on 0.5% agarose gels and transferred to Gene Screen 
Plus membrane. Synthetic oligonucleotide probes representing regions of 
the exons 1,2,3,4, and 5 of the human tyrosinase gene and 12 base-long 
cos-arm probes of the vector were end-labeled by polynucleotide kinase 
(NEB) and used to hybridize the filters . The sequences of the oligonucleo-
tide probes of regions of human tyrosinase gene were, for exon 1, 5/-
CCTCCGCTGGCCATTTC-3'; for exon 2, 5/-CCTGGAAACCAT-
GAC-3 /; for exon 3, 5/-CATGTCCCAGGTACAGGA-3/; for exon 4, 
5'_CAGATCTTTGGATGAAATAAG-3'; and forexon 5, 5'-CTCTATT-
GCCTAAGCC-3/. Hybridizations were carried out overnight in a solution 
containing 6 X SSC, 5 X Denhardt reagent, 0.5% sodium dodecylsulfate, 
100 Jlg/ml denatured fragmented salmon sperm DNA, and 1 X 106 
epm probe/ml solution . The filters were washed in solution containi.ng 
0 .1 X SSC and 0.5% sodium dodecylsulfate rwo degrees below the hybnd-
ization temperature, and exposed to the X-ray fi lm (X-OMA T, Kodak). The 
relative mobilities of the hybridized bands were determined and a restriction 
map of the human tyrosinase gene was constructed. 
Promoter Sequencing A 6-kb Bgl II fragment containing the 5' flank-
ing region and the first exon from pCos 28A was subcloned in the pGEM3 
(Promega, Madison, WI) vector. The 6-kb fragment also contained rwo 
EeoR I sites that were exploited for generating fragments of smaller length . 
Each smaller EcoR I fragment was subcloned in the pGEM 7 vector (Pro-
mega, Madison, WI). The nucleotide sequence of the 2.2-kb 5' flanking 
region from the A TG codon was determined by dideoxy chain termination 
sequencing using Sequenase (United States Biochemical Corporation, OH). 
T7 and SP6 primers and rwo other synthetic oligonucleotide primers, each 
of 16-bp lengths, corresponding to the antisense strand of the human tyro-
sinase gene were used for sequencing. The sequences of the primers used 
were 1) 5/-GCTGTAGCCATATTGT-3' and 2) 5/-TGGTGGGCTGA-
TATTA-3 /, located at -963 and -1254 bases, respectively, upstream of the 
A TG codon of the human tyrosinase gene. 
Sequence Analysis Computer analysis of the 2.2-kb 5' flanking sequence 
of the promoter was performed using the Pustell sequence analysis program 
(IBI, New Haven, CT) for homology search with reported sequences of 
different cis-acting clements involved in transcription regulation. The 
human tyrosinase sequence was also compared with 5' flanking sequences of 
mouse promoters, using the sequence-match program. 
Primer Extension Analysis Two micrograms of poly(A)+ RNA from 
Genovese melanoma cells were annealed with 5 X 105 cpm of kinased oli-
gonucleotide primer at 20 · C ovemight in a buffer containing 0.4 M NaCl, 
40 mM PIPES (pH 7.0) , 1 mM ethylenediamine tetraacetic acid (pH 8.0), 
and BO% formamide. The primer was a 17 mer corresponding to the anti-
sense strand of the human tyrosinase gene with the sequence 5'-
GAAATGGCCAGGGGAGG-3' located 44 bp downstream of the ATG 
codon. The mixture was precipitated with ethanol and suspended in reaction 
buffer containing 50 mM Tris-Cl (pH 7.6), 60 mM KCl, 10 mM MgCl2 , 
1 mM dithiothreitol, 1 mM each dATP, dCTP, dGTP and dTTP, 1000 
U/ml RNAsin (Promega Biotech, Madison, WI), and 50 U AMV reverse 
transcriptase (BRL Gaithersburg, MD). The extension reaction was per-
formed at 37 · C for 2 h followed by the addition of 50 Jlg/ml RNase, and 
incubation for a?~ther 30 .min. The DNA was extracted with phenol-chlor-
oform and precipitated With ethanol. The precipitate was dissolved in for-
mamide buffer, heat-denatured, and analyzed on a sequencing gel. 
Cons.tr~ctioD of Promote~ Plasm ids From the 6-kb Bgl II fragment 
cO.ntammg the promoter regIOn and exon 1, a 2.02-kb portion was excised 
usmg Xmn I and Pst I enzymes. The Xmn I site lies at the 5' end of the 
2.02-kb fragment and the Pst I site is at 13 bases downstream of the major 
transcription start site. This 2.02-kb fragment was initially subcloned in the 
pBluescnpt II KS vector and isolated from pBluescript using the Sal I and 
Xba I sites .to facilitate direct cloning at the Sal I-Xba I sites of the pCAT 
vector. TIllS fragment was subcloned into the Sal I and Xba I (5' and 3' 
duectIOns, respectively) sites upstream of the CAT gene of a pCAT -Basic 
vector (Promega, Maidson, WI) to yield the pHTY-CAT plasmid. 
Deletion Mutants Deletion mutants from the 5' end of the 2.02-kb 
tyrosinase promoter of pHTY -CAT plasmid were generated by treatment 
with exonuclease III using the Erase-a-base system (Promega). Ten micro-
grams of the plasmid DNA was first cut with Sph I, generating a 3' over-
hang, followed by digestion with Sal I, generating a 5' overhang. Following 
the double dIgestion, the linear plasmid was purified by phenol extraction, 
dissolved in 50 Jll exonuclease III buffer (66 mM Tris-Cl, pH B.O, and 0.66 
mM MgCI2) , and incubated at 30 · C prior to the addition of the exonuclease 
III enzyme. Two hundred fifty units of exonuclease III were added to the 
DNA, mixed quickly, and placed in 30· C, and aliquots were removed at 
regular intervals of 60 seconds. The aliquots were mixed with 20 Jll of Sl 
nuclease mix containing Sl buffer (30 mM potassium acetate, pH 4.6, 0.25 
M NaCl, 1 mM ZnSO., and 5% glycerol) and 300 U/ml Sl nuclease on ice. 
The samples were incubated for 30 min at room temperature followed by the 
addition of 1 Jll ofS1 stop buffer (0.3 M Tris and 0.05 M ethylenediaminete-
traacetic acid), then heated at 70 · C for 10 min to inactivate the S 1 nuclease. 
The samples were transferred to 37"C and 1 Jll of KIenow mix (20 mM 
Tris-Cl, pH B.O, 100 mM MgCl 2 , and 0.1 U/ml Klenow polymerase) was 
added and incubated for 15 min. The products were separated on a 1 % 
agarose gel and the DNA fragments isolated using Gene Clean kit (LaJolla, 
CAl. The samples were ligated overnight at 15 · C, transformed into Esche-
richia coli and grown on ampicillin plates. Clones containing suitable dele-
.tions were identified by performing restriction enzyme digestion of plasmid 
DNA prepared from 5 ml cultures, and the exact length of each deletion was 
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Figure 2. Primer extension analysis to 
determine the human tyrosinase gene 
transcriptional initiation site. A 17 base 
end-labeled oligomer primer, comple-
mentary to the coding strand of human 
tyros inase gene, 44 bases downstream of 
ATG, was hybridized with poly(A)+ RNA 
isolated from Genovese cells and extended 
using reverse transcriptase. The non-cod-
ing strand of the sequenciJ1g ladder ob-
tained by extending with the same primer 
using a genomic DNA template was used 
to locate the precise position of transcrip-
tional start sites. 
AC G T 
-42 
-34 
determined by dideoxy sequencing of each clone using a pCAT plasmid 
primer. 
Transfection and Enzyme Assays pHTY -CAT plasmids were trans-
fected into HeLa cells by the diethylaminoethyl (DEAE)-dextran method 
[19] and into melanoma cells, by electroporation [20]. For DEAE dextran 
transfection, cells were grown to a density of 0.5 X 106 cells/100 mm cul-
ture dish . Prior to the addition of DNA in DEAE-dextran, cells were washed 
in Dulbecco's modified Eagle's medium without serum, followed by the 
addition of 4 ml Dulbecco's modified Eagle's medium with 10% feta l bovine 
serum. Twenty micrograms of cesium chloride- purified pHTY -CAT plas-
mid DNA and 2 J.lg of CMV -p-galactosidase (p-gal) internal-control plas-
mid were dissolved in 40 J.lI Tris-buffered saline (25 mM Tris, 135 mM 
NaCI, and 2.5 mM KCl) and mixed with 80 J.lI sterile 10 mg/ml DEAE-
dextran solution (Pharmacia). The DNA in DEAE-dextran solution was 
slowly spread on HeLa cells in Dulbecco's modified Eagle's medium, swirled 
gently, and incubated for 4 h at 37 "C. The medium with DEAE-dextran 
was removed from the dishes and a 10% dimethylsulfoxide (DMSO) in 
phosphate-buffered saline (pH 7.4, PBS) shock was given for 1 min. The 
DMSO was removed immediately with excess PBS. The cells were then 
subjected to chloroquine (0.1 mM in DMEM) treatment for 90 min and later 
grown in fresh DMEM with fetal bovine serum at 37"C for 60 h~efore 
harvesting. 
For transfection by electroporation, cells were harvested from culture 
dishes and resuspended in FlO medium at a concentration of2 X 106 cells/ 
m!. For each transfection, 1 X 106 cells were aliquoted to individual cu-
vettes, 20 J.lg of pHTY -CAT plasmid, and 2 J.lg of p-gal internal-control 
plasmid were added and chilled on icc for 10 min. Electroporation was 
carried out at 380 volts and 980 J.lF capacitance using a Progenitor II pulsar 
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(Hoefer Scientific) . Cells were then incubated on ice for 10 min, transferred 
to culture dishes with 10 ml of medium, and grown at 37 "C for 60 h prior to 
harvesting. 
Cells were harvested by scraping and were washed two times with PBS. 
The cell pellets were suspended in 100 J.ll 0.25 M Tris, pH 8.0, and lysed by 
three cycles of freeze-thawing. Cell extracts were collected after centrifuga-
tion at 12,000 rpm for 10 min at 4 "C. Activities of p-gal and CAT were 
determined following standard methods [21]. Volumes of cell extract used 
for CAT assay were normalized based on p-gal activities in each sample. All 
transfections and enzyme assays were performed in duplicate. 
RESULTS 
Structure of the HUIllan Tyrosinase Gene Using the human 
tyrosinase eDNA probe Pmel 34, we isolated two independent re-
combinant cosmid clones and three lambda phage clones that con-
tained portions of the human tyrosinase gene. Our restriction analy-
sis data on four of the five clones indicated overlap of the regions 
between clones pATY3 and pATYIII, pATYIII and pATYIV, 
pATYIV and pCosTYV, which enabled us to costruct the map of 
the human tyrosinase gene. The gene spans a distance of approxi-
mately 65 kb. The clone pCos28A contained a 6-kb promoter re-
gion, first and second exons, first intron, and a 10-kb region of the 
second intron. Clones pATYIII, pATYIV, and pCosTYV contained 
the third, fourth, and fifth exons, respectively. The distances be-
tween each exon and the positions of the restriction sites on the 
human tyrosinase gene, based on our mapping strategy, are indi-
cated in Fig 1. The intervening sequence (IVS) 1 spans a distance of 
approximately 22 kb. Our restriction-mapping data did not give an 
overlap of pCos28A, which contains the first and second exons with 
that of either pATY3 or pATYIII, which contained the third exon 
regions; hence, we could not determine precisely the length ofIvS 
2. Nevertheless, our results clearly indicate the IVS 2 to be the 
largest intron, with a length of more than 26 kb. IVS 3 and IVS 4 
were found to be approximately 10 kb and 9 kb, respectively. The 
clone pCosV also contained a 13-kb portion of the 3' flanking 
region of exon 5. 
Identification of the Transcription Start Site To determine 
the transcription initiation site, a 17 -base - long synthetic oligomer 
complementary to the non-coding strand was end-labeled, hybrid-
ized with poly(A)+ RNA isolated from Genovese cells, and ex-
tended with reverse transcriptase. The extension product was ana-
lyzed on a sequencing gel and the precise size of the transcripts 
determined by comparison to a corresponding genomic DNA se-
quence ladder generated alongside, using the same primer employed 
for primer extension. The results of the primer extension analysis 
indicated a m~or transcription start site situated 42 bases upstream 
from the ATG codon, and three minor transcription start sites at 34, 
78, and 79 bases upstream of ATG. Three of these four sites started 
at A preceded by C (Fig 2). 
5' Flanking Sequence Analysis To characterize the promoter 
region of the human tyrosinase gene, the nucleotide sequence of2.2 
kb of the 5' flanking region subcloned in pGEM vector was deter-
mined (Fig 3) . Sequence analysis of the promoter indicated the 
presence of initiator and enhancer sequences. A TAT A box was 
identified at -27 bp upstream from the transcription start site, and a 
CAA T box was found at -128 bp upstream. In addition to these, 
there were also five putative AP-1, two AP-2, two glucocorticoid-
responsive elements (GRE) , three Oct-1, and two UV-responsive 
elements found at different regions of the human tyrosinase pro-
moter. Apart from these transcription regulatory elements, there 
was also a unique 230-base -long purine-rich domain present at 
-634 bases upstream from the transcription start site. 
Functional Analysis of the Tyrosinase ProIlloter Our earlier 
experiments on the mouse tyrosinase gene promoter indicated that a 
2.1 -kb portion of the promoter. was sufficient for producing pig-
mentation in transgenic mice [13]. With this observation ill mind, 
we studied the promoter function of a 2.02-kb 5' flanking region of 
the human tyrosinase gene in a transient expression system. To 
determine the promoter region that controls the human tyrosinase 
gene expression, a series of 5' deletion mutants of the 2.02-kb pro-
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-~l28 TAGACTGTTGAGTACAACACGTGTAGGCCAGAGCAGACAGTGGCCTATAC -1028 ATTGAGATGATCAAAAATATTTGCTGAAGTAAATATATTTCTCCTTTTCA 
-2178 TTGGGACAAATAAAGAGGTCTGTCCTATTTAAGAAAATCAACCCTGTAAA -978 ~CTAATTGAGAATGTCTTTGCACAAAACACATTGCAAAAACAT 
AP-1 
-2128 GGAAATTAATAGGACTAAGTACATTTTAGTAAGGCCTCTAAGCAGGCTCT -928 TTTCAAAAAAATTCCTAATTTCTAGAATTGATAGGAAAAACAATATGGCT 
-2078 AAAGATTATGAAAAATACACGGGACAGCAGACACAAAAGCCCTTAAAGAG -878 ACAGCATTGGAGAGAGAGAGAAAGGAAGAGGAGAAAGGAGAGAGAGAGAA 
-2028 CATGAAGACTTTCTAAGTTATTTCACTGGAAGCCTGATAGTGGGGCAAGT -828 AGGAGAGAGGAGAGAGACAGAGGAGAGAGAGAGAGGATAGAGGGGGAGAG 
-1978 GTAAGGCAAAATTCTTAATTAAATTGAAAATGATAAGTTGAATTCTGTCT -778 AGAGAGAGGAGAGAGACAGAGGAGAGAGAGAGAGGATAGAGGGGAGAGAG 
Figure 3. Nucleotide se-
quence of the human tyro-
sinase gene promoter as 
determined by dideoxy 
sequencing. The consen-
sus cis-acting elements and 
close homologs are indi-
cated in bold; • Transcrip-
tion start sites as observed 
by primer extension analy-
sis. The A TG codon is in-
dicated by double IHlder/il/e. 
The sequence data has 
been submitted to Gen-
Bank under the accession 
number U03039. 
-1928 TCGAGAACATAGAAAAGAATTATGAAA~TGTGGTTACAAGTAA 
OIl. 
-728 AGGGAGAGGGAGACAGAGGGAGAGAGAGGGAGAGAGAGAGAGAGAGAGGG 
-1878 TGCAGACCCAaOOCTCCCCAOOGACAAGAAGTCTTGTGTTAACTCTTTGT 
-678 AGAGAGAGAGAGAAAGAGAGAGAGAGGGAGAGAGAGAGAGAGAGCTCTTT 
AP-2 AP-2 
-1828 GGCTCTGAAAGAAAGAGAGAGAGAAAAGATTAAGCCTCCTTGTGGAGATC 
-628 AACGTGAGATATCCCACAATGAACAAATCTGCCCAGTTATCAAAGTGCAG 
-1778 ATGTGATGACTTCCTGATTCCAGCCAGAGCGAG~GAAACTT 
Oot-l 
-578 CTATCCTTAGGAGTTGTCAGAAAATGCATCAGGATTATCAGAGAAAAGTA 
-1728 CTCTTCCTCTTCACCCACACACTGCTCCATGTACCTGCAAaGCCTQtTCT 
oa. 
-1678 ~GTTGTTTCGATGAGCCGTGACllllll111ICTTAAATA 
-528 TCAGAAAGAIIIIIIIIICTGATACGTTGTATAAAATAAACAAACTGAAA 
-478 TTCAATAACATATAAGGAATTCTGTCTGGGCTCTGAAGACAATCTCTCTC 
H-1 
-1628 ATGAGACAAACTCCAGAAAAAGAGAAAAAAGCAGAGCAGTCTGACATTCC 
-428 TGCATATTGAGTTCTTCAAACATTGTAGCCTCTTTATGGTCTCTCAGAAA 
-1578 GGCATCATCGAAATAGTGATGGCTTTTCCTAGAATGCTTCAGCTAAGGAC 
-378 TAACTACCTTAAACCCATAATCTTTAATACTTCCTAAACTTTCTTAATAA 
-1528 CCAAAATACTAATGATCTCCTCAAAGCTTCAGAGGGGCAACTTTGATTTG 
-328 GAGAAGCTCTATTCCTGACACTACCTCTC~GGTCAAATCATCA 
Oct-1 
-1478 ACTACTCTTTTTGTCACTCTTCAGCTCACAAAAGAGCTCACTTTAGTTCA 
-278 TTAGTTTTGTAGTCTATTAACTGGGTTTGCTTAGGTCAGGCATTATTATT 
-1428 AAACACAAAGCTTTAAGCCCCTCCATAGATTGGTCCAOarrraaTTTTCT 
-228 ACTAACCTTATTGTTAATATTCTAACCATAAGAATTAAACTATTAATGGT 
oa. 
-1378 ATGATGAGTGGAGGCCTCAGTTTAATGCTCCAACTTGATAGATGAAACAC 
-178 GAATAGAGTTTTTCACTTTAACATAGGCCTATCCCACTGGTGGGATACGA 
-1328 AGTTCCCTCCTCTACACATTTCCC~GGAGTTTGTATATATTCT 
-128 ~CGAAAGAAAAAG~TGTGCTTTTCAGAGGATGAAAGCT 
AP-1 CAT-box AP-1 
-1278 CAGTTGTCTGTCCAACTTATGCCCACTCTTTGAGATATTAATCAAGGCAC 
-78 TAAGATAAAGACTAAAAGTGTTTGATGCTGGAGGTGGGAGTGGTATtAta 
TATA 
-28 %AGGTCTCAGCCAAGACATGTCATAATCACTGTAGTAGTAGCTGCAAAGA -1228 TCCL~qaraaCaCTTGCaTATTATTATCAAAATTATGCAATTCTTTCTA 
ORB, oot-l -box •• 
-1178 ATATCAGCCCACAAATACATCTCTTCCATTAAAAG~TTATCT 
AP-1 
GAAATCTGTGACTCCAATTAGCCAGTTCCTGCAGACCTTGTGAGGACTAG 
. . 
-1128 ATACTACTCATTTGAAAACTAACATAGTTAAGTTGTATTTTTAGCCATGA AGGAAG~CTCCTGGCTGTTTTGTACTGCCTGCTGTGGAGTTTCCAGA 
-1078 ATTTCAGTTTCCCTAGCTCACTATACACAGAGAAGGAAACTTTTGAAATA CCTCCGCTGGCCATTTCCCTAGAGCCTGTGTCTCCTCTAAGAACCTGAT 
mater was generated. The deleted constructs fused upstream to the 
CAT gene of a reporter plasmid were transfected into melanoma 
cells for the transient expression analysis. 
Results of the CAT assays in human melanoma cells indicated 
that the highest activity was produced with the pHTY-CAT plas-
mid containing the entire -2020 bp region of the human tyrosinase 
promoter. All other CAT activities are e~pressed as percentages of 
this value. Deletion of the promoter regIOn upstream to -1739 bp 
rapidly decreased the CAT activity, indicating that important en-
hancer elements were present between -1739 and -2020 bp up-
stream. When the deletion reached -550 bp, there was 26 percent of 
CAT activity compared to that of -2020 bp construct. Further dele-
tions covering -488, -258, and -83 bp of the promoter region also 
showed markedly decreased CAT activity, i.e., less than 2% of the 
-2020 bp fragment (Fig 4). 
DISCUSSION 
We mapped the gene for human tyrosinase to chromosome 11 q 14-
q21 [4] . In the present investigation, we have i~olated r~combinant 
cos mid and lambda phage clones that contamed regIOns of the 
human tyrosinase gene and we have performed restriction mapping 
of the entire human tyrosinase gene. The entire gene was found to 
encompass a distance of approximately 65 kb from the transcription 
start site to exon 5 (Fig 1). The IVS 1 and 2 are longer than IVS 3 and 
4. The sequence of the coding region of the human tyrosinase gene 
has already been determined by us and others [3,6,8]. Primer exten-
sion analysis indicated a major transcription start site at 42 bases 
upstream of the ATG codon. Apart from this, there were also three 
minor transcription initiation sites at regions 34, 78, and 79 bases 
upstream from the A TG codon. The transcription initiation sites at 
-42 and -79 bases upstream of ATG were reported earlier by Kiku-
chi et at [22] and differs from the earlier reports of T akeda et at [23] 
and Giebel et at [9] . The transcription initiation sites of our investi-
gation started with an A preceded by C , as is commonly observed in 
other eukaryotic genes [24] . The discrepancies in the mRNA start 
site determination could also be due to the different cell lines used in 
each study. Similar differences in transcriptional start sites were also 
observed in the mouse tyrosinase gene with different pigment cell 
lines [11,25] . 
Earlier works on human tyrosinase gene promoter [9 ,22] have 
analyzed the nucleotide sequence of up to 1 kb region upstream of 
the transcription start site. To understand the promoter function in 
detail with regard to the control elements involved in human tyro-
sinase gene expression, we sequenced 2.2-kb tyrosinase gene pro-
moter region. Analysis of the nucleotide sequences of the 5' flarlk-
ing region of the human tyrosinase gene indicated the presence of 
several transc:iption initiatior and enhancer elements. The most 
common motifs, TATA box and CCAAT, were found at regions 
-27 and -128 bp upstream of the transcription initiation site, respec-
tively. Apart from this, there was a core AP-l site with the sequence 
TGAGCTCA [26] found at -1297 bases upstream and four other 
close-consensus sequences for AP-l were found at regions -103, 
-971, -11 35, and -1 673 bases upstream of the transcription initia-
tion site. Two close-consensus sequences for AP-2 element [27] 
were found far upstream from the initiation site at -1856 and -1865 
bp. Sequences similar to the glucocorticoid-responsive element [28] 
were found at -1379 and -1679 bases upstream. Oct-1, ~n appar-
ently ubiquitous element in most mammalian cells [29] was found at 
three regions -293, -1209, and -1737 bases upstream . Sequences 
resembling the core UV -responsive element [30] were found at 
-1216 and -1894 bases upstream. The presence of various cis-acting 
elements in the promoter region of the human tyrosinase gene 
probably indicate that tyrosinase gene transcription is mediated by 
multiple regulatory elements. 
We further investigated the promoter function of the human 
tyrosinase gene using a transient expression system to define the 
areas of the 5' flanking region that playa vital role in transcriptional 
regulation. Maximal CAT activity was found il,1 the plasmid con-
struct containing the entire 2.02-kb promoter region and 26% of 
CAT activity of the 2.02-kb promoter was observed in a construct 
bearing 0.55-kb of the promoter. Constructs bearing 1.73 kb and 
1.17 kb, as well as those having 0.43 and 0.25 kb regions of the 
promoter, produced less than 2 percent of the value of2.02 kb (Fig 
4) . This observation indicates that a potentially-important region 
for human tyrosinase gene expression should lie beyond 1.73 kb 
upstream of the transcription start site. This observation is similar to 
that of Shibata et at [31] who have also identified the presence of an 
important region in human tyrosinase promoter between -1.8 kb 
and -2 kb upstream of transcription site. Though the presence of 
transcription initiator elements such as TAT A and CAA T sequences 
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Figure 4. CAT assay of pHTY-CAT reporter gene deletion series in a 
human melanoma cell line. N ested deletions of the human tyrosinase gene 
promoter were created by sequential digestion of the plasmid pHTY -CAT 
with Sph I, Sal I , and exonuclease Ill. Twenty micrograms of pHTY-CAT 
plasmids were co-trans fee ted with 2 /lg of CMV -/l gal DNA o n to Stilling 
cells by e1ectroporation. The cells were cultured for 60 h and harvested, and 
cel l extracts were used for CAT assay. The size of the human tyrosinase 
promoter upstream of the A TG codon is denoted as base pairs linked to the 
CAT gene on the left end and the relative CAT activity of each construct is 
shown in corresponding /iguore on the right. Each transfection was per-
formed in duplicate and a mean value recorded for the enzyme activity . 
are contained within the first 150-bp region, it appears that they 
may not be adequate in controlling tyrosinase gene expression. We 
have also perfor.med similar transient transfection experiments with 
the pHTY -CAT constructs on HeLa cells and we observed no ac-
tivity in any of them, including the longest 2.02-kb promoter. 
However, the reference plasmid that we used, pCAT -control plas-
mid with SV40 promoter and enhancer, showed equally efficient 
CAT activity in both melanoma and HeLa cells (data not shown). 
This observation also indicates the tissue-specific expression of the 
tyrosinase gene promoter. The presence of other ubiquitous cis-
acting elements in the promoter of the tyrosinase gene also suggests 
their interactions with probable tissue-specific elements in deter-
mining the transcription regulation. This could also be a factor in 
the observation of 26% reporter gene activity in plasmid constructs 
bearing 0.55 kb of the promoter. Our initial observation of the 
transcription-controlling regions of the human tyrosinase gene 
lends insight and impetus to further explorations for the precise 
determination of the nature of cis-acting sequences and trans-acting 
factors involved in human tyrosinase gene expression. Moreover, 
the information that a 2.02-kb region of the human tyrosinase gene 
promoter to be functionally effective in its transcription regulation 
could form a basis for future work in areas of gene transfer, since 
tyrosinase gene expression is melanocyte-specific. 
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